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This paper reviews the technical developments in microbiology that led to the discovery of
new infectious agents and the effect of these discoveries on establishing proof of causation. In
bacteriology, these advances included the light microscope, bacterial stains, bacterial cultures,
and the methods used to isolate clones. In virology, they involved the use offilters to separate
viruses from bacteria, the electron microscope, the use of laboratory animals, embryonated
eggs, tissue cultures to identify or grow the agent, and the recent development of molecular
techniques to detect the presence ofantigen in tissues. In immunology, theywere based on the
discovery ofantibodies and ofthe immune response.
Dedication
This paper is dedicated to the late Arthur J. Viseltear, Associate Profes-
sor ofthe History of Medicine and Public Health. He was a dear friend and
colleague, and a frequent luncheon companion on the third floor of the
Laboratory of Epidemiology and Public Health. There, his wit and wisdom
enlivened ourconversation on an almost dailybasis. His lectures andwriting
on the history ofpublic health, as well as his personal encouragement ofmy
efforts, were an inspiration to me in mymodestwritings oncertain aspects of
this subject. It is an honor to have this opportunity to express my devotion
and indebtedness to him in this memorial issue ofThe YaleJoumalofBiology
andMedicine.
INTRODUCTION
Our knowledge of the causation of infectious diseases depends on two major
aspects: the conceptual and the technical. The former is concerned with our
knowledge of the natural history of disease and its pathogenesis; the latter is
concerned with the laboratory techniques available at the time to identify the
organism, visualize it, grow it in the laboratory, reproduce the disease in an
experimental animal, and explain how the organism causes the disease. The famous
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TABLE 1
Henle-Koch Postulates
1. The parasite occurs in every case of the disease in question and under circumstances which can ac-
count for the pathological changes and the clinical course ofthe disease.
2. It occurs in no other disease as a fortuitous and non-pathogenic parasite.
3. After being isolated from the body and repeatedly grown in pure culture, it can induce the disease
anew.
Henle-Koch postulates of causation (Table 1) [1,2], which for over 100 years have
guided investigators in establishing the causal relationship of an organism to a
disease, were limited by conceptual issues that I have previously reviewed [3] and
which are summarized in Table 2.
This paper will review the technical developments which preceded Koch, and
which permitted him to evolve his evidence of causation, particularly for tuberculo-
sis. I will then present subsequent technical advances, up to the present time, which
have permitted the identification ofneworganisms, each ofwhich involved establish-
ing the possible causal relationship to the disease fromwhich itwas isolated. In some
cases, the discovery of the organism preceded recognition of the disease state with
which it was associated. In other cases, the organism discovered by the new
technique could not be cultivated in the laboratory or could not be reproduced in an
experimental animal, thus not fulfilling the Henle-Koch postulates for causation.
BACTERIOLOGY
The major discoveries and examples ofthe organisms found are given in Table 3.
A few points should be emphasized at the start of this discussion. As has been
stated so well by Bulloch in his great and comprehensive book, The History of
Bacteriology [4], most advances have evolved in a series of small steps based on the
work of several successive investigators, and also the application of the method was
not always made byits discoverer or even bythosewho laterperfected the technique.
The discussion that follows was derived largely from the works of Bulloch [4] and
of Foster [5] for bacteriology, and from that ofFenner and Gibbs [6] and Hughes [7]
TABLE 2
Limitations ofKoch'sa Postulates ofCausation
1. Not applicable to all pathogenic bacteria
2. May not be applicable toviruses, fungi, parasites
3. Do not include the following concepts:
a. The asymptomatic carrier state
b. The biologic spectrum ofdisease
c. Epidemiologic elements ofcausation
d. Immunologic elements ofcausation
e. Prevention ofdisease by elimination ofputative cause as ele-
ment ofcausation
f. Multiple causation
g. One syndrome having different causes in different settings
h. Reactivation oflatent agents as cause ofdisease
i. Immunologic processes as cause ofdiseases
aMore properly termed the Henle-Koch postulates
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TABLE 3
Technical Developments and the Discovery ofMicrobial Causes of Disease
Development
1. Light microscope
2. Laboratory animals:
Guinea pig
Ferrets
Adult mice
Suckling mice
Chimpanzee
Armadillo
3. Bacterial culture
(agar culture)
4. Embryonated eggs
5. Tissue culture:
Monkey kidney
Adult human
Embryonic human:
Lung WI-38
Cord lymphocytes
Brain
6. Electron microscope
7. Fluorescent antibody
Examples
M. leprae
M. tuberculosis, Legionnaires' disease
Influenza
Herpes simplex, yellow fever
Coxsackie and newer arboviruses
Hepatitis B, kuru, Creutzfeldt-Jakob disease
Leprosy
Most bacteria, especially Legionnaires',
Campylobacteria, Yersinia
Herpes, smallpox, some influenza viruses
Enteroviruses, Lassavirus
Polio, adeno, RS
Cytomegalovirus, rhinoviruses, corona virus
Epstein-Barr virus
Papova (JC strain)
Hepatitis A, rotavirus
Epstein-Barr virus
M.pneumoniae, etiology ofinfectious
mononucleosis
forvirology, in which the original references are cited. Bulloch, in particular, has an
excellent reference section and abriefsketch ofall the important microbiologists [4].
TheLightMicroscope
This instrument evolved at the end ofthe sixteenth orbeginningofthe seventeenth
century and was based on much older knowledge of the art of making convex and
concave lenses. The Dutchman, Antony van Leuwenhoek, was said to be the first to
apply the light microscope to (1) the identification oflivingprotozoa, in 1675, and (2)
to bacteria, in 1675 [4]. This remarkable man ground his own lenses and made some
400 single biconvex microscopes (really more like magnifying glasses), which were
capable of enlarging objects some 300 times. In addition to his activities as a lens
grinder and microscopist, he was also a draper, haberdasher, wine gauger for the
town ofDelft, and a qualified surveyor. His discoveries with his microscopes included
descriptions of bacteria found in his own teeth and other various morphological
bacterial forms, such as cocci and spiral forms. His description ofa motile animalcule
which he found in his own feces was, in all probability, Giardia lamblia and, ifso, was
the first parasitic protozoa to be observed in man [4,8].
Bacterial Stains
Proper morphological description of organisms under the light microscope re-
quired some method of staining them to identify their characteristics better. The
earliest efforts were apparently those of Hermann Hoffman in 1869, who employed
carmine andfuchsin stains; the formerwas alsousedbyWeigert in 1871. The staining
of bacteria as an art is said to have begun, however, when Weigert showed that
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methyl violet stain can reveal cocci in tissues [4]. Robert Koch improved on the
method by preparing thin films on cover glasses, drying and fixing them in alcohol,
and then using various stains, of which methyl violet SB, fuchsin, and analin brown
were the most successful. Paul Ehrlich introduced methylene blue, and, by adding an
alkali to the dye, which allowed it to penetrate bacilli, Koch was able to identify the
tubercle bacillus in 1882. This technique was also the basis of Loeffler's methylene
blue stain in 1884 [10]. Ehrlich improved the method of staining the tubercle bacillus
by heating the slide and using aniline dye in a technique that was named the
Ziehl-Nielsen acid-fast stain. Based on these observations, in 1884 Christian Gram, a
Dane, developed (some say by accident) the stain that bears his name, which was
made by adding Lugol's solution of iodine, followed by alcohol, and the Ehrlich stain
(aniline-water-gentian violet). This stain is still used routinely today: every laboratory
applies it to identify an unknown organism. Indeed, the first question in bacteriolog-
ical classification is whether an organism is Gram-positive or Gram-negative.
Pure Cultures ofBacteria
In order to study specific bacteria, it was necessary both to find an appropriate
medium for their pure culture and a technique to separate out individual organisms,
or clones, to determine the homogeneity of the bacteria. Many workers were
involved in these tasks, including Pasteur, Cohn, Loeffler, and Klebs. Edwin Klebs
(1834-1913) had worked with the tubercle bacillus and with anthrax at the same time
as Koch, or even slightly before, and apparently made the first attempts to obtain
separate cultures by a technique he termed the "fractional method." Oscar Brefeld,
a great mycologist, laid down the basic principles ofobtaining pure cultures based on
studies of fungi. These observations were published in some 18 volumes. Joseph
Lister, the Scottish surgeon who introduced aseptic techniques into the operating
room, invented a specially constructed syringe with a graduated nut which could
deliver volumes as small as l/loo of a minim. After a millionfold dilution, he was able to
deliver a drop containing a single bacterium. In this way he separated single colonies
of Bacterium lactis in 1878. Other workers, such as Nagele, Fitz, Hansen, and
Salomonsen also used this dilution technique to obtain pure cultures. Parentheti-
cally, it was this dilution technique by which Albert Sabin, some 100 years later, was
able to obtain attenuated strains of poliomyelitis viruses that formed the basis of his
oral vaccine. In bacterial cultures, it was Robert Koch who devised methods of
isolating pure cultures that are still used today. His method was based on the use of
clear nutrient gelatin with 1 percent meat extract. He prepared sterile slides, over
which the medium was poured, inoculated with a platinum wire or needle, and then
placed in a test tube with the sterile gelatin on a slant or upright. This method was
demonstrated in 1881 with great acclaim before a distinguished audience in London,
which included Lister and Pasteur. By 1883, Koch had improved the technique by
mixing the bacterial inoculum with melted gelatin and pouring it over cold sterile
glass plates. Students from all over the world flocked to Koch's laboratory in Berlin
to learn the method. The ability to separate out and grow a single organism lent great
specificity to the search for the causative agent of a disease. In virology, molecular
techniques now permit identification of specific viruses, their genetic variability in
human passage, and the genomic properties that determine pathogenicity and
clinical response patterns. Epidemiologically, these tools in both bacteriology and
virology have permitted the tracing of epidemics due to a specific strain of the
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organism, to differentiate between reactivation of an agent and exogenous reinfec-
tion, and to identify many molecular characteristics ofthe microbial agent responsi-
ble for pathogenicity, virulence, and the pattern of host response. For example, the
change in even one amino acid may alter avirus so that it ispathogenic, as in the case
ofrabiesvirus.
VIROLOGY
The technical developments discussed above for bacteriology had little influence
on the field ofvirology because viruses differ from bacteria in at least two essential
ways: (1) except for the large vaccinia virus, most viruses are smaller in size than
bacteria and cannot be seen under the light microscope; viruses require an electron
microscope for theirvisualization; (2) viruses cannotbe grown inbacterial mediabut
depend on living tissues for their multiplication, either in a living organism or in
tissue cultures derived from human or animal tissues. Thus, the major developments
that permitted virology to emerge as a separate discipline were based on filtration
methods, by which viruses could be separated from bacteria and other large
parasites, the discovery ofthe electron microscope, and the development ofsuscepti-
ble animal models and oftissue cultures.
The poxviruses represent the prototype virus and smallpox the prototype disease
on which most major developments invirology were first made. The large size ofthe
virus, its ease of cultivation in the laboratory, and the characteristic features and
epidemic importance of the disease it produced were the major reasons for this
beginning. The historical importance ofthevirusbecomesclearly apparentwhenone
reads Frank Fenner's chapter on "The Poxvirus" in the book, Portraits of Viruses,
which was edited by him and Adrian Gibbs [10]. The story of the conquest of
smallpox has also been told in magnificent detail in a beautifully illustrated book,
Smallpoxand itsEradication, editedbyFenner, D.A. Henderson, andothers [11].
ViralFilters
In 1892, Demitri Isoifirch Iwanowski, a graduate student at the University of St.
Petersburg, discovered that tobacco mosaicvirus could pass through a filterthat held
back bacteria. Six years later, and without knowledge of the Russian's work,
Martines William Beijerinck also found this virus to be filterable, and called it
"contagium vivum fluidum" [7]. Much later, but of fundamental importance to the
sizing ofviruses, was the development ofgraded membrane filters by Elford in 1931.
The earliest classification of viruses was based on sizing by this method. Later,
morphological and biochemical methods became available for classification. Today,
these are being replaced by molecular techniques, by which the genomic properties
and amino acid sequences can be determined.
Electron Microscope
The first electron microscope was built in 1932 by Knoll and Ruska [12], and the
first pictures of avirus, that oftobacco mosaicvirus, were shown in 1939 by Kausche
et al. [13]. Over time, and with improvement in techniques, almost all human and
animal viruses have been visualized under the electron microscope. The exceptions
to this statement are the slow, or unconventional, viruses, which are now referred to
as "prions" because the infectious particle appears to be protein in nature, rather
than nucleic acids (RNA or DNA), which characterize conventional viruses. These
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prion agents cause a number of diseases of animals and man, including a spongiform
encephalopathy of sheep (scrapie), mink, and cattle, and kuru, Creutzfeldt-Jakob
disease (CJD), and Gerstmann-Straussler-Schenker syndrome (GSS) in humans.
Through the development of methods in preparation, such as metal shadowing,
negative staining, freezing, and osmic acid fixation, the morphological appearance of
the external surfaces of conventional viruses and bacteria became well characterized
under the electron microscope. Plaque counting techniques permitted quantitation
of their numbers, and the addition of specific immune sera, which resulted in
clumping, allowed specific identification of viral groups (termed "immune electron
microscope" or "direct virology" when applied to clinical specimens). Most of these
studies involved known viruses that had been identified by other techniques. The
electron microscope has also been the means of discovering new viruses or, at least,
of first visualizing viruses suspected of causing a disease, but for which the web of
causation was indirect. Two examples of the former will be given and one of the
latter.
In 1964, Epstein, Achong, and Barr [14] reported the presence of viral particles
under the electron microscope in cultures of lymphoblasts derived from Burkitt's
lymphoma, a childhood tumor of African children first described in detail by Denis
Burkitt, an English surgeon [15]. The particles were found to be a new herpes virus,
distinct from herpes simplex, varicella zoster, and cytomegalovirus. It was eventually
called Epstein-Barr virus (EBV). While identified in Burkitt tumor tissue, its causal
relationship to this tumor remained unclear until added means of identifying the
presence ofEBV or its antibody became available. The latter technique was provided
by Gertrude and Werner Henle in 1966 [16], when they developed an immunofluo-
rescence test for identifying IgG antibody to the viral capsid antigen of the virus. This
advance led to both case-control and prospective studies that implicated EBV as an
initiator of the pathogenesis of the tumor by creating a proliferation of B lympho-
cytes. This rapid multiplication ofB lymphocytes was augmented by malaria, which is
also a B-cell mitogen, and which also impairs the cytotoxic T-cell response to such
proliferation. The rapid multiplication of B cells resulted in a chromosomal translo-
cation (from chromosome 8 to chromosome 14, 2, or 22), and, with this, the
activation of an oncogene, c-myc, which was the final step in the appearance of a
malignant cell whose clonal multiplication constitutes Burkitt's lymphoma.
The discovery of the immunofluorescence test for EBV also led in 1968 to the
discovery by the Henles and Volker Diehl [17] that EBV was the cause of infectious
mononucleosis. It is ironic that Werner Henle was the grandson of Jakob Henle, who
proposed the first criteria for causation of an infectious disease in 1840 [1], yet none
of these criteria were met by his grandson in establishing the causal proof that EBV
caused infectious mononucleosis. Indeed, neither EBV nor hepatitis B virus fulfilled
the pre-existing postulates of Henle-Koch [1,2], Rivers [18], or Huebner [19]. These
viruses required new ones based on immunological evidence [20], consisting of (1)
the appearance of specific antibody to the agent during the course of the disease, (2)
that such immunity protected against primary infection, (3) that only persons lacking
the antibody were susceptible to the infection, and (4) that no other antibody could
induce similar immunological events.
Another important group of viruses discovered by means of the electron micro-
scope were the rotaviruses. These were identified in duodenal cells and stools of
children with acute gastroenteritis in Australia by Bishop and associates in 1973-74
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[21,22]. Proof of causation rested on regular identification of the virus in sick
children and the appearance ofviral-specificantibody. Experimentalreproductionof
the clinical disease in animals was not possible, and even initial isolation in tissue
cultures was extremely difficult. The diagnosis by immune electron microscopy of
both virus and antibody was a major technique used for viral identification until
easier methods, such as radioimmunoassay and the ELISA (enzyme-linked immu-
nosorbent assay) tests were developed. It is now recognized that this group of
rotaviruses is the cause of some 30-S50 percent of cases of acute gastroenteritis in
children under three years old worldwide. Vigorous attempts to develop a vaccine
with attenuated human strains or animal rotaviruses (the so-called Jennerian ap-
proach) are under way. Unfortunately, the diversity of rotavirus strains and their
poor antigenic properties are making this research a difficult task. Enough evidence
of homotypic protection from avaccine is at hand, however, to indicate fulfillment of
one of Huebner's criteria for causation, i.e., that a vaccine prepared from the
putative cause should decrease the incidence ofthe disease [19].
The demonstration of hepatitis A virus in stool samples under the electron
microscope by Feinstone et al. [23] not only established visually the presence of the
virus in the intestinal tractbut also was the basis for the immune electronmicroscope
test for diagnosis. This diagnostic test confirmed epidemiological evidence derived
from human volunteer experiments that the virus could be transmitted by the
fecal-oral route. Attempts to reproduce the disease in non-human primates had
failed (although infection occurred), as had many early attempts to grow thevirus in
tissue culture. Later, and with much difficulty, it was successfully adapted to growth
in tissue culture by Provost and Hilleman in 1979 [24]. This success paved the wayfor
development of a vaccine, a task now being vigorously pursued with both killed and
attenuated viral preparations. At present, the outlook appears very good for an
effective vaccine. Evidence that such a vaccine decreases or eliminates the disease
would also provide a final step in the causal proof that hepatitis A virus causes
infectious hepatitis.
EmbryonatedEggs and Tissue Cultures
Tissue cultures of rabbit and guinea pig cornea had been shown by Steinhardt et
al. [25], as early as 1913, to sustain thegrowth ofvacciniavirus, and, in the same year,
poliomyelitis virus was reported to grow in cultures ofspinal ganglia by Levaditi [26].
Neither of these methods were widely adopted, however, because of the difficulty of
maintaining the cultures free of bacterial contamination; control of this problem
awaited the discovery of antibiotics. In the meantime, the chicken embryo was
discovered to be an important way to cultivate viruses. For example, in 1931
Woodruff and Goodpasture [27] showed that fowlpox virus replicated on the
chorioallantoic membrane of developing chicken embryos. Subsequently, other pox
viruses and herpes simplex viruses were cultivated in a similar manner, each
producing characteristic plaques on the membrane. Many otherviruses, such as the
myxoviruses (influenza, Newcastle disease virus, and mumps) were also found to
grow in the amniotic sac or allantoic cavity ofthe chick embryo, and many rickettsiae
multiplied in the yolk sac. For these microbial agents, the chick embryo was not the
initial means of discovery but provided an important media for diagnosis and for
theirgrowth forvaccines.
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A major breakthrough in the use of tissue cultures occurred in 1949 when Enders,
Robbins, and Weller reported the growth of poliovirus in tissue cultures derived
from various human embryonic sources [28], for which work they were awarded the
Nobel prize in 1954. Primary kidney cultures were also shown to be capable of
supporting the growth of poliovirus and were the main source of cells for polio
vaccines. The addition of antibiotics to their cultures had prevented bacterial and
fungal contamination. The use of tissue cultures rapidly expanded from this point
onward; however, these two early tissue culture cells did not grow continuously and
thus required fresh material for every new viral passage. Other cell lines, derived
from human (HeLa, Hep-2, WI-38) and animal sources (Vero), were then developed
and shown to multiply continuously in culture. They provided appropriate substrates
for the growth of many viruses and for the production of many vaccines. The WI-38
cell line, in particular, was used for many vaccines because it was derived from
normal human embryonic lung tissue and did not pose the potential oncogenic
problem of introducing cell lines derived from a human malignancy or from an
animal source into humans.
Tissue cultures of various sorts also led to the discovery of many new viruses.
These included several viruses that cause acute respiratory infections, such as
rhinoviruses, adenoviruses, parainfluenza viruses, and respiratory syncytial virus, and
also of viruses causing acute infections of the central nervous system, such as the
large group of enteroviruses and of some Coxsackie viruses. The tissue culture
systems also provided a method of isolating and propagating exanthem viruses, such
as measles and rubella, for vaccine production. Vero cells from green monkey
kidneys were also an important growth medium for arboviruses.
The evidence for a causal association of these new viruses with the clinical
conditions from which they had been isolated came primarily from such viral
isolation, as well as the specific antibody responses to them. Reproduction of these
diseases in laboratory animals proved very difficult, except for polioviruses, arbovi-
ruses, and measles virus. Measles virus had been shown capable of producing a rash
in monkeys as early as 1921 [29].
In 1967,I published a list of "Five Realities of Acute Respiratory Disease" [30] to
indicate that (1) the same syndrome could be produced by several agents; (2) the
same virus could produce several clinical syndromes; (3) the cause of the syndrome
varied by geographic area, age, and other factors; (4) the causes of only about half of
the common acute respiratory and intestinal syndromes and of about one-quarter of
acute viral infections of the central nervous system have been identified; and (5)
diagnosis ofthe etiological agent could rarely be made on clinical grounds alone and
required laboratory methods such as isolation of the virus and/or demonstration of
an antibody response. These same concepts were found later to apply to many
syndromes of infectious and chronic diseases as well as to many malignancies. These
observations meant that a given virus or bacteria might be established as the cause of
a given disease in one setting, but that, in another geographic area or another age
group, some other infectious agent might result in the same clinical picture.
More recently, the growth of human B and T lymphocytes in suspension cultures
has led to the discovery of several important groups of viruses. B-type lymphocytes,
derived from lymph node biopsies of cases of Burkitt's lymphoma, were successfully
grown in vitro in 1964 both by Epstein and Barr [31] and by Pulvertaft [32]. As
discussed above, examination of such cultured cells under the electron microscope
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TABLE 4
Duesberg's Objections to the Concept That HIV Causes AIDS'
1. Infections with no or low risk for AIDS indicate the virus is not sufficient to cause AIDS.
2. The long incubation period ofAIDS is incompatible with the short latent period ofviral replication.
3. Levels ofAIDS virus expression and infiltration appear too low to account for AIDS or other dis-
eases.
4. AIDSvirus is not directly cytocidal.
5. AIDS virus is an indicator of a low risk for AIDS.
'Derived from [39].
led to the discovery ofEpstein-Barr virus (EBV) [14]. Indeed, EBV was found to be
necessaryfor the continual growthofB lymphocytes in the laboratory, their so-called
"immortalization." This virus infects B cells at a receptor site on the cell similar to
the receptor ofC3 complement.
T-type lymphocyteswere more difficult to culture butwere found tomultiplyin the
presence of T-cell growth factor. This finding led to the discovery of four human
retroviruses, originally designated as human T-cell lymphotropicviruses.
The first ofthese, HTLV-I,was isolated in 1980byPoiez et al. [33] and is the cause
of adult T-cell leukemia, as well as of tropical spastic paraparesis [34]. It occurs
primarily in Japan and in the Caribbean islands. The second, HTLV-II, was isolated
in 1982 from T cells of a patient with a T-cell variant of hairy cell leukemia [35]. Its
full clinical spectrum is unknown. The third, HTLV-III, now called human immuno-
deficiency virus, type 1, or HIV-1, was isolated from lymphocytes of patients with
AIDS by Montagnier and his group in France in 1983 [36] and by Gallo and
associates at the National Institutes ofHealth in the United States in 1984 [37]. The
virus has been propagated in large amounts in special lymphocyte cultures, also
developed in Gallo's laboratory in 1984 [38], which has permitted extensive work on
the biological, biochemical, andgenetic make-up ofthevirus.
While HIV is widely regarded as the cause ofAIDS, and this belief is the basis of
ournational prevention campaign, avigorous and outspoken opponent to thisview is
Peter Duesberg, a distinguished molecularvirologist at the University ofCalifornia,
Berkeley [39,40]. Duesberg's majorobjections, included in his first paper in 1987, are
listed in Table 4, to which I have replied in detail [41]. Although much argument
back and forth has been published [42-45], he remains firm in his beliefthat HIV is
not the cause ofAIDS. In fact, he feels it hasnothing to dowith the disease, even as a
co-factor, and continues to publish detailed virological and epidemiologic papers in
support ofhisview [46,47].
A fourth human retrovirus, HTLV-IV, now designated as HIV-2, has also been
isolated in lymphocyte cultures by Clavel et al. [48] and by Kanki et al. [49] and is
another cause ofAIDS, although not as pathogenic to the immune system as HIV-2
[48].
In addition to the retroviruses, a new herpes virus, originally called human
B-lymphotropicvirus (HBLV) and nowtermed human herpesvirus, type 6 (HHV-6),
has been isolated, initially from lymphocytes of a case ofAIDS, and subsequentally
from healthy donors, infants with exanthem subitum, and patients with the chronic
fatigue syndrome [50,51]. The virus can multiply in both B- and T-type lymphocytes.
The prevalence ofantibody to thisvirus hasbeenofthe orderof60 percent in healthy
donors, indicating that it is avery common and often asymptomatic infection. A true
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causal relationship to primary infection with the virus appears to exist for exanthem
subitum (roseola infantum), a common, febrile rash in young children, and with rare
casesofan infectiousmononucleosis-like syndrome inyoungadults [52,53]. Thevirus
is easilyreactivated, and antibody hasbeenfound in high titer in 80 percent or so ofa
number of chronic and malignant conditions, such as the chronic fatigue syndrome,
Hodgkin's disease, African Burkitt's lymphoma, and acute lymphocytic leukemia
[52]. In most ofthese disease settings, the presence ofhigh antibody titers appears to
represent reactivation ofthe virus and not a primary causal association.
LaboratoryAnimals
Animal species of all types and sizes have been used for the induction ofinfection
and diseaseby bacteria andviruses ever since the earlywork ofKlebs and Kochwith
tuberculosis and anthrax, and of Pasteur with rabies. In his 1955 book on animal
viruses, Burnett presents a table listing the animal species employed in the study of
19viruses, beginningwith the 1879 inoculation ofrabbitswith rabiesvirus byGaltier,
and ending with the isolation of Coxsackie viruses in 1948 by Dalldorf and Sickles
[54]. The latter is ofparticular importance because that was the means bywhich this
group of viruses was first found, and it raised the problem of causal association in
patients with a non-paralytic polio-like disease, from which it was first isolated.
Members of the Coxsackie group have now been shown to be the cause of a wide
variety of clinical syndromes involving the central nervous system, respiratory tract,
skin, and diaphragmatic pleura.
Another example ofthe first identification ofan agent in an experimental animal is
that of kuru, a chronic and fatal degenerative disease of the central nervous system
occurring in natives ofthe Fore tribe in New Guinea. In 1966 Gajdusek and hisgroup
at the National Institutes ofHealth successfully transmitted the disease to chimpan-
zees [55]. The transmission of this disease in humans was associated with cannibal-
ism. By inoculation ofbrain material from cases ofthis disease into chimpanzees, the
researchers were able to reproduce the disease clinically and pathologically after a
long incubation period. The pathological picture resembled a sponge, so that the
name spongioform encephalopathies has been applied to this group of agents. The
long incubation period led to the term "slow viruses," and the lack of DNA or RNA
in the agents, theirhigh resistance to heat and chemicals, and their lackofinducing a
demonstrableantibodyresponse resultedinthedesignation"unconventionalviruses."
The infectious particle appears to be a form ofprotein called "prion," and the term
"prion" diseases has been suggested for this group, rather than "viruses," because
they lack the nucleic acids characteristic of all conventional viruses. The cause of a
similar condition, Creutzfeldt-Jakob disease (CJD), also produced a similar clinical
and pathological disease in chimpanzees and other experimental animals. The
finding that these infectious agents could produce chronic degenerative infections of
the central nervous systems of humans was a key discovery, significant enough for
Gajdusek to receive the Nobel prize. Because these agents could not be grown in
tissue culture, nor antibody to them demonstrated, they gave rise to an new set of
guidelines for causation. These were published in 1974 by Johnson and Gibbs [56].
The guidelines were based on the reproducibility and serial transmission of the
disease in an experimental animal in several laboratories and on the exclusion of
otherpossible agents contaminating the material.
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OtherLaboratory Techniques
The agar gel immunodiffusion method for demonstrating precipitin bands that
form when antigen and antibody interact was the key technique that permitted
Blumberg et al. in 1965 [57] to discover a new antigen found in the blood of
Australian aborigines. Initially, it was called "Australia antigen" because it was not
known what disease, if any, was associated with its presence. Subsequent epidemio-
logical and clinical studies by Prince in 1968 [58] established thevirus as the cause of
a type ofhepatitisformerlycalled "serum" or "transfusion-associated" hepatitis, but
now known to be transmitted by other parenteral routes, by close contact, and from
infected mothers to theiroffspring. When infectionwith thisvirus occurs early in life,
as is true in Africa and Asia, the antigen persists in the blood in about 90 percent of
those infected andleads tocirrhosisofthe liverand tohepatocellularcarcinoma. For
his discovery, Blumbergwas also awarded the Nobel prize, in 1976.
New molecular techniques involving DNA probes and, more recently, the poly-
merase chain reaction (PCR), are revolutionizing our basic tools in microbiology
[59]. They provide very powerful and highly sensitive techniques for identifying
antigen in human tissues. Use ofPCR, forexample, has identified Epstein-Barrvirus
in tissues from Hodgkin's disease [60]. As reviewed by Eisenstein [59], the method is
being employed to identify the presence of small amounts of viral, bacterial, and
parasitic antigens in various tissues, including blood. For example, it has permitted
the identification of HIV in the blood of 90 percent of AIDS patients, even well
before antibody appears. It is also present in some infants born of HIV-infected
mothers and provides a method to indicate that the infant is infected, since it is
impossible to determine for sixmonths or so ifthe antibody in the infantwas derived
from the mother or was the result of active infection ofthe newborn. The method is
currently too complex and expensive, however, for such routine diagnostic tests. The
PCR technique is based on amplification of impure DNA by simple chemical
proliferation in vitro ofapredetermined stretch ofDNA [59]. The method is capable
ofamplifyingspecific DNA sequences more than a millionfold in only a few hoursby
an automated procedure. At a practical level, it is being applied to the diagnosis of
bothviral and bacterial infections, aswell as to the search forknownviral antigens in
cancer tissues, such as HTLV-I in T-cell lymphomas, EBV in various lymphomas,
hepatitis B and Cviruses in livercancer, andpapillomaviruses incervical cancer [61].
The high sensitivity of the technique also leads to some false-positive reactions,
especially cross-contamination from true-positive samples, which have been previ-
ouslytested in the same laboratory. Carefulwashingofequipment is essential. While
an extremely important method of seeking known microorganisms, the requirement
of prior knowledge of a DNA fragment of the infectious agent under study for
amplification limits its application with respect to unknown agents. Other molecular
techniques, however, have enabled investigators to clone the virus of hepatitis C
(HCV) and to develop an antibody test for it before it has been grown in tissue
culture, seen under the electron microscope, or serologic identification or genome
characterization has been possible. This development has been described by Alter
[62] under the interesting title, "Descartes before the horse: I clone, therefore I am.
The hepatitis Cvirus in current perspective."
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Akeyelement in establishing that an infectious agent causes aparticular disease is
the demonstration of the appearance of a specific antibody to the agent, or of a
fourfold increase in antibody titer, ifantibody is already present when the specimen
is taken. The presence of agent-specific IgM antibody is usually indicative of a
primary infection, although certain reactivated infections, such as cytomegalovirus,
are accompanied by a small IgM response. Another highlyimportant discovery is the
development of techniques for producing quantities of highly specific monoclonal
antibodies, which was first published by Kohler and Milstein in 1975 [63]. The
application ofmonoclonal antibodies toviral diagnosis has greatly enhanced demon-
stration ofthe specificityofthe immune response, permitting differentiation between
strains of the same agent and of differentiation of a reactivated infection from one
due to exogenous reinfection.
Another important arm ofthe immune response in that ofcell-mediated or T-cell
immunity, which is demonstrable by skin tests, and is useful in the clinical diagnosis
of infection due to agents that cannot be grown in culture and/or for which an
antibody response is notproduced: The organism that causes leprosy,M. leprae, is an
example.
This section will briefly review the history of the key developments and is derived
from Bulloch [4], Foster [5], and Bellanti [64]. Only key original references derived
from these sourceswill be cited.
Antibodies and the ImmuneResponse
The observation by Edward Jenner that persons who got well after cowpox were
immune to smallpox led to his introduction ofcowpoxvaccine in 1798 [65]. This was
an empiric discovery without scientific basis at the time, but the concept on which it
was based has withstood the test of time and has eventually led to the complete
eradication of smallpox from the world in 1977. About 100 years after Jenner's
publication, Louis Pasteur and his associates began the scientific approach to
immunology by preparing attenuated strains of microorganisms for protection
against infectious diseases, first with fowl cholera vaccine in 1878-80 [66] and then
with anthrax in 1881 [67]. Based on Jenner's contribution, Pasteur coined the term
"vaccine" (from vacca, Latin for cow) for these immunizations. The use of these
living attenuated, as well as heat-killed, cultures, for prophylaxis against infectious
diseases, constitutes active immunization. The proof that this type of immunity,
calledhumoral immunity, was due to antibody production occurred with the sentinel
observation ofBehring and Kitasato in 1890 [68]. They demonstrated the neutraliz-
ing antitoxic activityofsera from animals immunizedwith tetanus toxin and also that
this antitoxic activity protected the animals against infection. This observation was
followed one week laterby a paper byBehring alone, showing the same to be true of
diphtheria toxin. In theirjoint paper, it was also shown that the neutralizing activity
of tetanus antitoxin could be transferred by serum from immunized animals to
uninoculated animals andwould result inprotection, a process nowknown aspassive
immunization. In 1895, Calmette published evidence ofthe neutralizing property in
snake venom antiserum [69]. A mechanism to explain how antibody is produced and
how it actswas proposed by Paul Ehrlich in 1897 andwas termed the "side-chain" or
"receptor" theory [70].
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Afterviruseswere discovered, itwas found that the production ofa demonstrable,
specific immune antibody response occurred much more frequently in viral than in
bacterial diseases and constituted a critical element ofviral diagnosis. An important
test to demonstrate humoral antibodies was the complement fixation test developed
by Bordet and Gengou in 1901 [71]. This method is still used as one of the most
common diagnostic procedures inviral diagnostic laboratories around the world.
While many testswere developed to demonstrate the immune response, itwas not
until 1937 that Rivers suggested that the appearance of specific antibody during a
viral infection constituted an important element in establishing causation [18], a
suggestion reaffirmed in the guidelines suggested by Huebner in 1957 [19]. Huebner
also added the concept that longitudinal epidemiological studies were helpful in
establishing causation, as was the demonstration that protection against infection
followed the use of a vaccine prepared using the candidate causal agent. Later, for
infectious agentswhichcould notbe grown in tissue culture, the demonstration ofan
immune response to the candidate agent constituted the major basis for causal
inferences. Examples of this type are the role of EBV in infectious mononucleosis
and that of hepatitis B virus in viral hepatitis. These criteria, based on the immune
response, were published by Evans in 1974 [20].
In addition to humoral immunity, an important arm ofprotection against infection
is that termed cell-mediated immunity or, in more modern terminology, B- and T-cell
immunity. On a practical basis, the most common method to demonstrate the
presence ofthis type ofimmunity is the use ofa skin test, inwhich a small amount of
the antigen is inoculated intracutaneously and followed for 24-72 hours for the
appearance of an indurated, red reaction at the site of injection. Perhaps the first
demonstration of this phenomenon and of its use as a diagnostic test was the
discoverybyKoch ofthe tuberculin test [72]. Cell-mediated immunityisimportant in
the control ofviruses, fungi, and other intracellular bacteria and parasites. Although
the skin test is used in the diagnosis of many of these infections, it has not been
included as a criterion of causal proof of an infectious disease. For this reason,
further historical discussion ofits development will not be pursued.
SUMMARY
The technical developments reviewed in this paper have led not only to the
discovery of new organisms but also provided methods that have helped to identify
their role in the pathogenesis of the diseases with which they are associated. The
discovery of each new infectious agent has required evidence to establish the proof
that it causes the disease fromwhich it hasbeen isolated. Sometimes, the technology
has resulted in identifying agents which do not grow in culture or induce disease in
experimental animals, thus failing to fulfill the Henle-Koch postulates for bacterial
causation or those of Rivers and Huebner for viral diseases. This type of discovery
has resulted in the formulation of new postulates of causation for these infectious
agents.
In addition to these microbiological advances, important advances have occurred
in immunology, particularly the discovery of antibodies. These advances have led to
inclusion of the demonstration of the immune response in viral infections as a
criterion for establishing causation.
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